July 18, 2013
A study reporting omega-3s are linked to prostate cancer was widely reported in the media, but without a few key details, such as the studies flaws, contradictory finding s and a leap to discourage supplements. This INSIDER TV News Desk discusses the study's findings, and explains why the study is not the last word in omega-3s and prostate health.
Learn more on the industry's take of the omega-3 prostate cancer study by reading the INSIDER article, "Industry Defends Omega-3 Supplements Against Cancer Study," or by checking out the SupplySide Omega-3 Insights article, "Media Hype on Omega-3s and Prostate Cancer Misrepresents Study Finding," written by Adam Ismail, executive director of the Global Organization for EPA and DHA Omega-3s (GOED).
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023